What is the Future of MS Therapy? Neuroprotection, and Blurred Lines Between Disease Phenotypes

May 31, 2020 /
MS Drug Therapies

When Ben Greenberg, MD,
MPH, was asked to present a talk for the 2020 Consortium of Multiple Sclerosis
Centers (CMSC) Virtual Annual Meeting on “Emerging Therapies Across the
Spectrum of Disease,” he got to thinking about what this “spectrum”
means, and how it affects the future of multiple sclerosis (MS) treatment.



 Read More…

Click HERE to Subscribe for the MS Beacon Newsletter

::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Information Shared by: MSViewsandNews
to and for those affected by Multiple Sclerosis
::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::


Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews

Stay informed with MS news and information - Sign-up here

For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT


Share:

Categories

Latest Blog Posts